Shares in Novo Nordisk fell as much as 30% after it slashed sales and profits forecasts for the second time this year amid pressure from rival Eli Lilly.Read More

You might also be interested in reading Committee of Global Regulators Calls on Banks to Minimize Risks of Crypto Assets.